Shopping Cart
- Remove All
Your shopping cart is currently empty
NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $54 | In Stock | |
| 5 mg | $113 | In Stock | |
| 10 mg | $183 | In Stock | |
| 25 mg | $313 | In Stock | |
| 50 mg | $413 | In Stock | |
| 100 mg | $596 | In Stock | |
| 200 mg | $791 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $125 | In Stock |
| Description | NRC-2694 is an antagonist of the epidermal growth factor receptor (EGFR). It has anti-cancer and anti-proliferative properties. |
| In vitro | NRC-2694 (80 ng) induce comparable inhibition of EGFR expression. |
| In vivo | NRC-2694 (10 mg/kg) regresses the tumor in mice. The maximum tolerated dose of NRC-2694 in male and female mice is 2000 mg/kg (p.o.), in toxicity studies . |
| Molecular Weight | 418.49 |
| Formula | C24H26N4O3 |
| Cas No. | 936446-61-6 |
| Smiles | COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCN1CCOCC1 |
| Relative Density. | 1.27 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 250 mg/mL (597.39 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.